SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $104,234 | -49.9% | 117,646 | -11.4% | 0.01% | -28.6% |
| Q3 2022 | $208,000 | -15.1% | 132,778 | +8.1% | 0.01% | 0.0% |
| Q2 2022 | $245,000 | +8.4% | 122,882 | +28.8% | 0.01% | +40.0% |
| Q1 2022 | $226,000 | -50.4% | 95,417 | +2.6% | 0.01% | -44.4% |
| Q4 2021 | $456,000 | +4966.7% | 93,026 | +8418.9% | 0.01% | – |
| Q1 2021 | $9,000 | -98.9% | 1,092 | -99.1% | 0.00% | -100.0% |
| Q4 2020 | $842,000 | -20.7% | 116,421 | +27.2% | 0.02% | -47.1% |
| Q3 2020 | $1,062,000 | +157.1% | 91,537 | +35.5% | 0.03% | +126.7% |
| Q2 2020 | $413,000 | – | 67,538 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
| Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
| Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
| Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
| ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
| Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
| EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
| TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
| GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
| Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |